Evidence map›Paper›PMID 40142576›Full record

ArticleMicroorganisms2025

Whole-Genome Sequencing of Linezolid-Resistant and Linezolid-Intermediate-Susceptibility

Pedro Martínez-Ayala, Leonardo Perales-Guerrero, Adolfo Gómez-Quiroz, Brenda Berenice Avila-Cardenas, Karen Gómez-Portilla, Edson Alberto Rea-Márquez, Violeta Cassandra Vera-Cuevas, Crisoforo Alejandro Gómez-Quiroz, Jaime Briseno-Ramírez, Judith Carolina De Arcos-Jiménez

Abstract read
In one paragraph

Article in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Linezolid in the Focus of Antimicrobial Resistance ofInternational journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Pedro Martínez-AyalaHIV Unit, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara 44280, Mexico.ORCID 0000-0002-0505-6340
Leonardo Perales-GuerreroDepartment of Internal Medicine, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara 44280, Mexico.
Adolfo Gómez-QuirozMicrobiology Laboratory, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara 44280, Mexico.
Brenda Berenice Avila-CardenasMicrobiology Laboratory, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara 44280, Mexico.
Karen Gómez-PortillaDepartment of Internal Medicine, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara 44280, Mexico.
Edson Alberto Rea-MárquezDepartment of Internal Medicine, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara 44280, Mexico.
Violeta Cassandra Vera-CuevasSequencing Research and Development, Abalat, Ciudad de México 14000, Mexico.ORCID 0000-0003-3767-6867
Crisoforo Alejandro Gómez-QuirozMicrobiology Laboratory, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara 44280, Mexico.
Jaime Briseno-RamírezHealth Division, Tlajomulco University Center, University of Guadalajara, Tlajomulco de Zuñiga 45641, Mexico.ORCID 0009-0006-1901-392X
Judith Carolina De Arcos-JiménezHealth Division, Tlajomulco University Center, University of Guadalajara, Tlajomulco de Zuñiga 45641, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Linezolid-non-susceptible

Indexed as

cfrEnterococcus faecalisgenomic surveillancelinezolid resistancemultidrug-resistant bacteriaoptrA

Identifiers

PMID40142576
PMCPMC11944505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.